Communication
Version 1
Preserved in Portico This version is not peer-reviewed
Re-thinking the Potential for Airborne Transmission of SARS-CoV-2
Version 1
: Received: 6 May 2020 / Approved: 7 May 2020 / Online: 7 May 2020 (13:20:42 CEST)
How to cite: Allen, J.; Marr, L. Re-thinking the Potential for Airborne Transmission of SARS-CoV-2. Preprints 2020, 2020050126. https://doi.org/10.20944/preprints202005.0126.v1 Allen, J.; Marr, L. Re-thinking the Potential for Airborne Transmission of SARS-CoV-2. Preprints 2020, 2020050126. https://doi.org/10.20944/preprints202005.0126.v1
Abstract
Evidence for the potential for airborne transmission of SARS-CoV-19 continues to accumulate, with important implications for healthcare workers, as well as the general public. Three lines of evidence support this conclusion.
Keywords
SARS-CoV-2; COVID-19; airborne; aerosol; transmission
Subject
Medicine and Pharmacology, Pulmonary and Respiratory Medicine
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (1)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
Commenter: Annette K.
The commenter has declared there is no conflict of interests.
Commenter: Knute Jensen
The commenter has declared there is no conflict of interests.
You are a rare voice expressing concern for airborne transmission while leading authorities are expressing otherwise. I am a regulator currently evaluating a request for emergency exemption to pesticide registration for a product that claims to disinfect the air. Expressed opinions of leading authorities such as the CDC and WHO would lead me to decline this request. I ask for your opinion of the value of adding a disinfectant to the air (assuming EPA could confirm efficacy and safety) knowing the availability of such a product, unlikely as it would be to interrupt the droplet transmissions, might also lead to less focus or care with known effective interventions (masks, distancing, maximized fresh air in buildings). This is a fairly urgent request and I welcome your thoughts. Thank you.
-Knute Jensen
Commenter:
The commenter has declared there is no conflict of interests.
Allen, J.G. and Marr, L.C. (2020), Recognizing and controlling airborne transmission of SARS‐CoV‐2 in indoor environments. Indoor Air, 30: 557-558. doi:10.1111/ina.12697